WO2018109496A3 - Unnatural amino acids - Google Patents
Unnatural amino acids Download PDFInfo
- Publication number
- WO2018109496A3 WO2018109496A3 PCT/GB2017/053768 GB2017053768W WO2018109496A3 WO 2018109496 A3 WO2018109496 A3 WO 2018109496A3 GB 2017053768 W GB2017053768 W GB 2017053768W WO 2018109496 A3 WO2018109496 A3 WO 2018109496A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amino acids
- unnatural amino
- arylation
- alpha
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
The present invention relates to a process for alpha-arylation of heterocyclic urea derivatives by aryl transfer rearrangement for the preparation compounds of Formula (I): wherein X, Z, Q, Ar, R1, R2, R3 and R4 are each as defined herein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1621512.1A GB2557931A (en) | 2016-12-16 | 2016-12-16 | Unnatural amino acids |
GB1621512.1 | 2016-12-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018109496A2 WO2018109496A2 (en) | 2018-06-21 |
WO2018109496A3 true WO2018109496A3 (en) | 2018-07-26 |
Family
ID=58284685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2017/053768 WO2018109496A2 (en) | 2016-12-16 | 2017-12-15 | Unnatural amino acids |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2557931A (en) |
WO (1) | WO2018109496A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008032684A (en) * | 2006-06-27 | 2008-02-14 | Nagasaki Univ | Absolute layout determining method of sugar and affinity aldehyde compound by high speed liquid chromatography |
WO2014062697A2 (en) * | 2012-10-16 | 2014-04-24 | Endocyte, Inc. | Drug delivery conjugates containing unnatural amino acids and methods for using |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0820698A2 (en) * | 2007-12-19 | 2019-09-24 | Wyeth Llc | 4-imidazolidinones as kv1.5 potassium channel inhibitors |
-
2016
- 2016-12-16 GB GB1621512.1A patent/GB2557931A/en not_active Withdrawn
-
2017
- 2017-12-15 WO PCT/GB2017/053768 patent/WO2018109496A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008032684A (en) * | 2006-06-27 | 2008-02-14 | Nagasaki Univ | Absolute layout determining method of sugar and affinity aldehyde compound by high speed liquid chromatography |
WO2014062697A2 (en) * | 2012-10-16 | 2014-04-24 | Endocyte, Inc. | Drug delivery conjugates containing unnatural amino acids and methods for using |
Non-Patent Citations (4)
Title |
---|
BACH RENAUD ET AL: "alpha.-Arylation of cyclic amines by aryl transfer in lithiated ureas", SYNLETT, GEORG THIEME VERLAG, DE, vol. 3, 13 February 2009 (2009-02-13), pages 421 - 424, XP002712398, ISSN: 0936-5214, DOI: 10.1055/S-0028-1087543 * |
GYORGYDEAK, Z. ET AL: "Synthesis and stereochemical studies of 6-substituted 1H,3H,6H,7aH-3,3-dimethylimidazo[1,5-c]thiazol-5-one-7-thiones", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 33, no. 4, 1996, pages 1099 - 1105, XP002778063, ISSN: 0022-152X, DOI: 10.1002/jhet.5570330417 * |
TAIT, MICHAEL B. ET AL: "2,2- and 2,6-diarylpiperidines by aryl migration within lithiated urea derivatives of tetrahydropyridines", ORGANIC LETTERS, vol. 17, no. 05, 18 February 2015 (2015-02-18) - 2015, pages 1236 - 1239, XP002778064, DOI: 10.1021/acs.orglett.5b00199 * |
TANAKA, TAKASHI ET AL: "Facile discrimination of aldose enantiomers by reversed-phase HPLC", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 55, no. 6, June 2007 (2007-06-01), pages 899 - 901, XP002778062, ISSN: 0009-2363, DOI: 10.1248/cpb.55.899 * |
Also Published As
Publication number | Publication date |
---|---|
GB2557931A (en) | 2018-07-04 |
WO2018109496A2 (en) | 2018-06-21 |
GB201621512D0 (en) | 2017-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019012815A (en) | Process for preparing optically active 2,3-dihydrothiazolo[3,2-a] pyrimidin-4-ium compounds. | |
WO2017123763A8 (en) | Processes for the preparation of 2,5-furandicarboxylic acid and intermediates and derivatives thereof | |
MX2018001491A (en) | Methods for preparation of bile acids and derivatives thereof. | |
EP4295841A3 (en) | Sulfur (vi) fluoride compounds and their use in click-reaction | |
TN2019000204A1 (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
WO2012044727A3 (en) | Manufacturing process for pyrimidine derivatives | |
SG10201902206QA (en) | Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof | |
AU2018253590A1 (en) | Imidazopyridazine compounds | |
PH12015501226A1 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same | |
MX2018003311A (en) | Crosslinked nucleic acid guna, method for producing same, and intermediate compound. | |
WO2016071361A3 (en) | Herbicidal compounds | |
WO2016038628A3 (en) | A process for preparing olodaterol and intermediates thereof | |
MX2020002449A (en) | Novel fungicidal heterocyclic compounds. | |
WO2016166720A3 (en) | Polymorphs of afatinib and its salts and process for the preparation of quinazolinyl derivatives | |
PH12020550905A1 (en) | Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives | |
WO2016071362A3 (en) | Herbicidal compounds | |
WO2019094552A8 (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
WO2016142819A3 (en) | Novel process for the preparation of ranolazine | |
MX2018000459A (en) | Production method for nitrogen-containing heterocyclic compound, and intermediate of said nitrogen-containing heterocyclic compound. | |
PH12019502509A1 (en) | Compounds and methods for treating bacterial infections | |
WO2015199418A3 (en) | Novel heterocyclic compound | |
MX2017008074A (en) | IMIDAZOPYRIDAZINE DERIVATIVES AS PI3Kß INHIBITORS. | |
WO2018060962A3 (en) | Metformin amino acid compounds and methods of using the same | |
PH12017500435A1 (en) | A salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof | |
WO2018109496A3 (en) | Unnatural amino acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17817843 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17817843 Country of ref document: EP Kind code of ref document: A2 |